Crude incidence rates of mortality, cardiovascular (CV) death and major adverse cardiovascular events (MACE), where MACE included myocardial infarctions (MI), cerebrovascular events and peripheral arterial disease (PAD) events
| Outcome | Controls n=42 380 | Patients with CML n=4238 |
| Mortality | ||
| Pre-2001 | 33.0 | 83.3 |
| 2001 or later | 21.4 | 41.9 |
| CV death | ||
| Pre-2001 | 13.8 | 9.3 |
| 2001 or later | 5.4 | 6.3 |
| MACE | ||
| Pre-2001 | 15.3 | 19.8 |
| 2001 or later | 12.6 | 20.3 |
| MI | ||
| Pre-2001 | 8.1 | 9.9 |
| 2001 or later | 6.3 | 9.4 |
| Cerebrovascular event | ||
| Pre-2001 | 7.3 | 8.6 |
| 2001 or later | 5.6 | 8.6 |
| PAD | ||
| Pre-2001 | 3.9 | 5.1 |
| 2001 or later | 3.0 | 6.9 |
Event rates are expressed per 1000 person-years’ follow-up.
CML, chronic myeloid leukaemia.